

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.36409594 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.97671446 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.89754395 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.89754395 |
| 5 | B cell receptor signaling pathway (GO:0050853) | 5.26029040 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.20849703 |
| 7 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.19028630 |
| 8 | positive thymic T cell selection (GO:0045059) | 4.98074374 |
| 9 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.81284793 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.76907773 |
| 11 | negative regulation of cell killing (GO:0031342) | 4.76907773 |
| 12 | regulation of gamma-delta T cell activation (GO:0046643) | 4.74593646 |
| 13 | detection of bacterium (GO:0016045) | 4.74109355 |
| 14 | detection of other organism (GO:0098543) | 4.73177485 |
| 15 | positive regulation of B cell differentiation (GO:0045579) | 4.68194656 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 4.66489820 |
| 17 | regulation of B cell differentiation (GO:0045577) | 4.55660067 |
| 18 | response to peptidoglycan (GO:0032494) | 4.22684573 |
| 19 | response to interleukin-15 (GO:0070672) | 4.14410127 |
| 20 | negative thymic T cell selection (GO:0045060) | 3.93530055 |
| 21 | leukocyte aggregation (GO:0070486) | 3.88861297 |
| 22 | thymic T cell selection (GO:0045061) | 3.87920821 |
| 23 | negative T cell selection (GO:0043383) | 3.84988277 |
| 24 | negative regulation of phagocytosis (GO:0050765) | 3.84981781 |
| 25 | tolerance induction (GO:0002507) | 3.82528437 |
| 26 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.82010037 |
| 27 | detection of external biotic stimulus (GO:0098581) | 3.76970361 |
| 28 | positive T cell selection (GO:0043368) | 3.74876758 |
| 29 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.72458017 |
| 30 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.61426318 |
| 31 | cellular response to zinc ion (GO:0071294) | 3.56973458 |
| 32 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.56724398 |
| 33 | response to host immune response (GO:0052572) | 3.56675400 |
| 34 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.56675400 |
| 35 | positive regulation of histone deacetylation (GO:0031065) | 3.55947107 |
| 36 | regulation of mast cell degranulation (GO:0043304) | 3.55040892 |
| 37 | T cell migration (GO:0072678) | 3.54317538 |
| 38 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.54228031 |
| 39 | neutrophil activation (GO:0042119) | 3.50470096 |
| 40 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.50063664 |
| 41 | cellular response to interleukin-15 (GO:0071350) | 3.49325095 |
| 42 | type I interferon signaling pathway (GO:0060337) | 3.48539162 |
| 43 | cellular response to type I interferon (GO:0071357) | 3.48539162 |
| 44 | T cell selection (GO:0045058) | 3.48506735 |
| 45 | response to type I interferon (GO:0034340) | 3.47645655 |
| 46 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.42411054 |
| 47 | myeloid cell activation involved in immune response (GO:0002275) | 3.41373567 |
| 48 | negative regulation of T cell mediated immunity (GO:0002710) | 3.35602250 |
| 49 | response to host (GO:0075136) | 3.34680976 |
| 50 | response to host defenses (GO:0052200) | 3.34680976 |
| 51 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.34680976 |
| 52 | detection of biotic stimulus (GO:0009595) | 3.32634242 |
| 53 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.32596893 |
| 54 | natural killer cell differentiation (GO:0001779) | 3.32542861 |
| 55 | immunoglobulin mediated immune response (GO:0016064) | 3.30096735 |
| 56 | cellular extravasation (GO:0045123) | 3.29580427 |
| 57 | mature B cell differentiation (GO:0002335) | 3.28281919 |
| 58 | T cell homeostasis (GO:0043029) | 3.27828590 |
| 59 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.24904053 |
| 60 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.24555013 |
| 61 | granulocyte activation (GO:0036230) | 3.24547036 |
| 62 | lymphocyte homeostasis (GO:0002260) | 3.23910087 |
| 63 | regulation of leukocyte degranulation (GO:0043300) | 3.23318924 |
| 64 | negative regulation of granulocyte differentiation (GO:0030853) | 3.23150278 |
| 65 | regulation of antigen processing and presentation (GO:0002577) | 3.21916935 |
| 66 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.21857189 |
| 67 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.18179478 |
| 68 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.15988531 |
| 69 | regulation of tolerance induction (GO:0002643) | 3.07754720 |
| 70 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.07325878 |
| 71 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.04517668 |
| 72 | positive regulation of antigen processing and presentation (GO:0002579) | 3.04001453 |
| 73 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.03778563 |
| 74 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.03778563 |
| 75 | positive regulation by symbiont of host defense response (GO:0052509) | 3.02266935 |
| 76 | modulation by symbiont of host defense response (GO:0052031) | 3.02266935 |
| 77 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.02266935 |
| 78 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.02266935 |
| 79 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.02266935 |
| 80 | modulation by symbiont of host immune response (GO:0052553) | 3.02266935 |
| 81 | macrophage activation (GO:0042116) | 3.02211590 |
| 82 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.01934668 |
| 83 | detection of molecule of bacterial origin (GO:0032490) | 3.01643940 |
| 84 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.00072673 |
| 85 | microglial cell activation (GO:0001774) | 2.98743081 |
| 86 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.98381179 |
| 87 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.97708555 |
| 88 | negative regulation of innate immune response (GO:0045824) | 2.94577663 |
| 89 | B cell homeostasis (GO:0001782) | 2.93101266 |
| 90 | positive regulation of mast cell activation (GO:0033005) | 2.92370607 |
| 91 | leukocyte degranulation (GO:0043299) | 2.92250069 |
| 92 | T cell costimulation (GO:0031295) | 2.91485695 |
| 93 | B cell proliferation (GO:0042100) | 2.90579557 |
| 94 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.89450604 |
| 95 | positive regulation of protein deacetylation (GO:0090312) | 2.89282568 |
| 96 | negative regulation of bone resorption (GO:0045779) | 2.89123054 |
| 97 | endothelial tube morphogenesis (GO:0061154) | 2.89082451 |
| 98 | morphogenesis of an endothelium (GO:0003159) | 2.89082451 |
| 99 | regulation of T cell tolerance induction (GO:0002664) | 2.87260555 |
| 100 | regulation of mast cell activation (GO:0033003) | 2.87207512 |
| 101 | positive regulation of lamellipodium assembly (GO:0010592) | 2.86863855 |
| 102 | T cell receptor signaling pathway (GO:0050852) | 2.86360802 |
| 103 | activated T cell proliferation (GO:0050798) | 2.85471037 |
| 104 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.85042085 |
| 105 | lymphocyte costimulation (GO:0031294) | 2.84825946 |
| 106 | lymph node development (GO:0048535) | 2.84694955 |
| 107 | megakaryocyte development (GO:0035855) | 2.84476723 |
| 108 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.83896255 |
| 109 | regulation of granulocyte differentiation (GO:0030852) | 2.83797181 |
| 110 | NIK/NF-kappaB signaling (GO:0038061) | 2.82878703 |
| 111 | leukocyte homeostasis (GO:0001776) | 2.82474968 |
| 112 | negative regulation of interleukin-6 production (GO:0032715) | 2.82327588 |
| 113 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.81735225 |
| 114 | negative regulation of B cell proliferation (GO:0030889) | 2.81660210 |
| 115 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.81479905 |
| 116 | leukocyte cell-cell adhesion (GO:0007159) | 2.81243389 |
| 117 | interferon-gamma production (GO:0032609) | 2.80503153 |
| 118 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.79795577 |
| 119 | negative regulation of interleukin-12 production (GO:0032695) | 2.78954600 |
| 120 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.78539106 |
| 121 | response to muramyl dipeptide (GO:0032495) | 2.76611600 |
| 122 | positive regulation of interferon-alpha production (GO:0032727) | 2.74000513 |
| 123 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.73707404 |
| 124 | regulation of B cell proliferation (GO:0030888) | 2.71470199 |
| 125 | positive regulation of isotype switching (GO:0045830) | 2.70315578 |
| 126 | response to laminar fluid shear stress (GO:0034616) | 2.68349009 |
| 127 | regulation of erythrocyte differentiation (GO:0045646) | 2.67211601 |
| 128 | defense response to protozoan (GO:0042832) | 2.66675924 |
| 129 | erythrocyte maturation (GO:0043249) | 2.63611776 |
| 130 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.63328594 |
| 131 | positive regulation of granulocyte differentiation (GO:0030854) | 2.62540801 |
| 132 | mature B cell differentiation involved in immune response (GO:0002313) | 2.62178261 |
| 133 | respiratory burst (GO:0045730) | 2.62160048 |
| 134 | response to protozoan (GO:0001562) | 2.61732717 |
| 135 | positive regulation of B cell activation (GO:0050871) | 2.61674865 |
| 136 | myeloid dendritic cell activation (GO:0001773) | 2.61293105 |
| 137 | B cell mediated immunity (GO:0019724) | 2.61161713 |
| 138 | angiogenesis involved in wound healing (GO:0060055) | 2.60461564 |
| 139 | natural killer cell activation (GO:0030101) | 2.58988348 |
| 140 | regulation of response to interferon-gamma (GO:0060330) | 2.58393983 |
| 141 | positive regulation of interleukin-2 production (GO:0032743) | 2.58310503 |
| 142 | regulation of interferon-alpha production (GO:0032647) | 2.57754155 |
| 143 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.56895927 |
| 144 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.56461417 |
| 145 | germinal center formation (GO:0002467) | 2.55680096 |
| 146 | macrophage activation involved in immune response (GO:0002281) | 2.55448944 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.83110117 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 4.18431822 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.92962316 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.62712261 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.53598454 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.42571677 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.17731284 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.15231767 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.88238230 |
| 10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.82115041 |
| 11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.82066942 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.78922596 |
| 13 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.67250384 |
| 14 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.64025889 |
| 15 | * MAF_26560356_Chip-Seq_TH1_Human | 2.54197986 |
| 16 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.40782725 |
| 17 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.37257845 |
| 18 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.37189877 |
| 19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.36496676 |
| 20 | MYB_26560356_Chip-Seq_TH2_Human | 2.35986014 |
| 21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.35125592 |
| 22 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.29605829 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.28633066 |
| 24 | MYB_26560356_Chip-Seq_TH1_Human | 2.24417860 |
| 25 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.23381303 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.20464463 |
| 27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.19514178 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18346440 |
| 29 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.14815101 |
| 30 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.08329722 |
| 31 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.04193379 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.02683001 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.02264541 |
| 34 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.01379882 |
| 35 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.01224535 |
| 36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.01114211 |
| 37 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.00411376 |
| 38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.96272305 |
| 39 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.95647581 |
| 40 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.91197177 |
| 41 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.89949241 |
| 42 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.88930773 |
| 43 | SPI1_23127762_ChIP-Seq_K562_Human | 1.80942222 |
| 44 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.80029555 |
| 45 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.77172619 |
| 46 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72232941 |
| 47 | * MAF_26560356_Chip-Seq_TH2_Human | 1.70819508 |
| 48 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.66286366 |
| 49 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64430972 |
| 50 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.58926859 |
| 51 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53393021 |
| 52 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52996669 |
| 53 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.51193166 |
| 54 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.46449140 |
| 55 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.44050581 |
| 56 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.42766655 |
| 57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.40108509 |
| 58 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.38614712 |
| 59 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.37157320 |
| 60 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.35214620 |
| 61 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.32379035 |
| 62 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.29744508 |
| 63 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.29337953 |
| 64 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28514088 |
| 65 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28221923 |
| 66 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28149988 |
| 67 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.23288351 |
| 68 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.20494017 |
| 69 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.19831389 |
| 70 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.19783893 |
| 71 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18967271 |
| 72 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.17298507 |
| 73 | * P68_20966046_ChIP-Seq_HELA_Human | 1.17226045 |
| 74 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.17120672 |
| 75 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.16141695 |
| 76 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.15509966 |
| 77 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.15277336 |
| 78 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.14751438 |
| 79 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.13959917 |
| 80 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.11687127 |
| 81 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.11173960 |
| 82 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10518987 |
| 83 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.09915063 |
| 84 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06914531 |
| 85 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05130170 |
| 86 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.03609433 |
| 87 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03542840 |
| 88 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03535146 |
| 89 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00817810 |
| 90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99976142 |
| 91 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99523456 |
| 92 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99186537 |
| 93 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98925255 |
| 94 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95891271 |
| 95 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95760169 |
| 96 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94854263 |
| 97 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.94411220 |
| 98 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93916638 |
| 99 | KDM2B_26808549_Chip-Seq_K562_Human | 0.92922852 |
| 100 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91291690 |
| 101 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90861133 |
| 102 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.90768525 |
| 103 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.90004034 |
| 104 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.89431869 |
| 105 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.88173989 |
| 106 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87958741 |
| 107 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.85677650 |
| 108 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.85230291 |
| 109 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.83362327 |
| 110 | GATA2_19941826_ChIP-Seq_K562_Human | 0.83313291 |
| 111 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.81946148 |
| 112 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.80155041 |
| 113 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79946479 |
| 114 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.79917612 |
| 115 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.79281023 |
| 116 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.79129518 |
| 117 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.78890212 |
| 118 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78603222 |
| 119 | GATA3_26560356_Chip-Seq_TH2_Human | 0.78403970 |
| 120 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.76056098 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.69741728 |
| 2 | MP0001800_abnormal_humoral_immune | 3.37096715 |
| 3 | MP0000685_abnormal_immune_system | 3.31395011 |
| 4 | MP0003303_peritoneal_inflammation | 3.27119418 |
| 5 | MP0005387_immune_system_phenotype | 3.20726915 |
| 6 | MP0001790_abnormal_immune_system | 3.20726915 |
| 7 | MP0002396_abnormal_hematopoietic_system | 2.99849753 |
| 8 | MP0005671_abnormal_response_to | 2.97798074 |
| 9 | MP0003763_abnormal_thymus_physiology | 2.90414428 |
| 10 | MP0002452_abnormal_antigen_presenting | 2.80092705 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.58416224 |
| 12 | * MP0002398_abnormal_bone_marrow | 2.57794873 |
| 13 | MP0002420_abnormal_adaptive_immunity | 2.57667408 |
| 14 | MP0002723_abnormal_immune_serum | 2.55151643 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.53190294 |
| 16 | MP0001819_abnormal_immune_cell | 2.52807590 |
| 17 | MP0003436_decreased_susceptibility_to | 2.32995931 |
| 18 | * MP0000689_abnormal_spleen_morphology | 2.24675959 |
| 19 | * MP0000716_abnormal_immune_system | 2.24593846 |
| 20 | MP0005025_abnormal_response_to | 2.13872947 |
| 21 | MP0002166_altered_tumor_susceptibility | 2.13854526 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.13052366 |
| 23 | MP0009278_abnormal_bone_marrow | 2.11451651 |
| 24 | * MP0002722_abnormal_immune_system | 2.10549270 |
| 25 | MP0002419_abnormal_innate_immunity | 2.07008205 |
| 26 | MP0009785_altered_susceptibility_to | 2.04502936 |
| 27 | MP0001873_stomach_inflammation | 2.01848336 |
| 28 | MP0002405_respiratory_system_inflammati | 2.01345661 |
| 29 | * MP0004808_abnormal_hematopoietic_stem | 1.95551434 |
| 30 | * MP0002429_abnormal_blood_cell | 1.94784458 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.93448491 |
| 32 | MP0000703_abnormal_thymus_morphology | 1.84881102 |
| 33 | MP0000465_gastrointestinal_hemorrhage | 1.81323119 |
| 34 | MP0005397_hematopoietic_system_phenotyp | 1.77074718 |
| 35 | MP0001545_abnormal_hematopoietic_system | 1.77074718 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.74713373 |
| 37 | MP0008260_abnormal_autophagy | 1.72396649 |
| 38 | MP0005451_abnormal_body_composition | 1.61353427 |
| 39 | MP0004510_myositis | 1.59091857 |
| 40 | MP0006082_CNS_inflammation | 1.58997430 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.57528120 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.56877534 |
| 43 | MP0002148_abnormal_hypersensitivity_rea | 1.56659795 |
| 44 | MP0004947_skin_inflammation | 1.52182601 |
| 45 | MP0002006_tumorigenesis | 1.48665325 |
| 46 | MP0001853_heart_inflammation | 1.43127646 |
| 47 | MP0003866_abnormal_defecation | 1.42227888 |
| 48 | MP0010352_gastrointestinal_tract_polyps | 1.38829595 |
| 49 | MP0002933_joint_inflammation | 1.36420180 |
| 50 | MP0002138_abnormal_hepatobiliary_system | 1.34836933 |
| 51 | MP0002132_abnormal_respiratory_system | 1.31491071 |
| 52 | MP0000490_abnormal_crypts_of | 1.29906262 |
| 53 | MP0003724_increased_susceptibility_to | 1.28017694 |
| 54 | MP0001879_abnormal_lymphatic_vessel | 1.25454568 |
| 55 | MP0003566_abnormal_cell_adhesion | 1.22786185 |
| 56 | MP0009764_decreased_sensitivity_to | 1.19768326 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.17854215 |
| 58 | MP0003077_abnormal_cell_cycle | 1.16246573 |
| 59 | MP0003075_altered_response_to | 1.14454032 |
| 60 | MP0010368_abnormal_lymphatic_system | 1.10858035 |
| 61 | MP0004381_abnormal_hair_follicle | 1.10689144 |
| 62 | MP0006054_spinal_hemorrhage | 1.10634539 |
| 63 | MP0008469_abnormal_protein_level | 1.09222842 |
| 64 | * MP0002019_abnormal_tumor_incidence | 1.08846008 |
| 65 | MP0003172_abnormal_lysosome_physiology | 1.07793236 |
| 66 | MP0010094_abnormal_chromosome_stability | 1.07119613 |
| 67 | MP0005076_abnormal_cell_differentiation | 1.07085286 |
| 68 | MP0005310_abnormal_salivary_gland | 1.02428994 |
| 69 | MP0010307_abnormal_tumor_latency | 1.02133900 |
| 70 | MP0005174_abnormal_tail_pigmentation | 1.01620058 |
| 71 | MP0003828_pulmonary_edema | 1.00407006 |
| 72 | MP0004883_abnormal_blood_vessel | 0.98868158 |
| 73 | MP0008961_abnormal_basal_metabolism | 0.98837029 |
| 74 | MP0003279_aneurysm | 0.98650528 |
| 75 | MP0000858_altered_metastatic_potential | 0.97982831 |
| 76 | MP0005023_abnormal_wound_healing | 0.97842883 |
| 77 | MP0003693_abnormal_embryo_hatching | 0.93877426 |
| 78 | MP0003448_altered_tumor_morphology | 0.93349916 |
| 79 | MP0003705_abnormal_hypodermis_morpholog | 0.92881895 |
| 80 | MP0005058_abnormal_lysosome_morphology | 0.91357928 |
| 81 | MP0003111_abnormal_nucleus_morphology | 0.90242633 |
| 82 | MP0005390_skeleton_phenotype | 0.87160975 |
| 83 | MP0003045_fibrosis | 0.86954400 |
| 84 | MP0008057_abnormal_DNA_replication | 0.86479753 |
| 85 | MP0003690_abnormal_glial_cell | 0.85849152 |
| 86 | MP0003183_abnormal_peptide_metabolism | 0.85283995 |
| 87 | MP0001851_eye_inflammation | 0.85019154 |
| 88 | MP0003656_abnormal_erythrocyte_physiolo | 0.83394384 |
| 89 | MP0003091_abnormal_cell_migration | 0.81825707 |
| 90 | MP0000767_abnormal_smooth_muscle | 0.81515862 |
| 91 | MP0000249_abnormal_blood_vessel | 0.81345600 |
| 92 | MP0000343_altered_response_to | 0.78244138 |
| 93 | MP0002277_abnormal_respiratory_mucosa | 0.77534482 |
| 94 | MP0000604_amyloidosis | 0.77423878 |
| 95 | MP0009840_abnormal_foam_cell | 0.75953763 |
| 96 | MP0008007_abnormal_cellular_replicative | 0.75702918 |
| 97 | MP0005164_abnormal_response_to | 0.75620048 |
| 98 | MP0000350_abnormal_cell_proliferation | 0.71976887 |
| 99 | MP0000313_abnormal_cell_death | 0.71590083 |
| 100 | MP0001915_intracranial_hemorrhage | 0.68029823 |
| 101 | MP0001663_abnormal_digestive_system | 0.67400560 |
| 102 | MP0003795_abnormal_bone_structure | 0.66871653 |
| 103 | MP0008004_abnormal_stomach_pH | 0.66597653 |
| 104 | MP0002136_abnormal_kidney_physiology | 0.66172346 |
| 105 | MP0000015_abnormal_ear_pigmentation | 0.65390175 |
| 106 | MP0002998_abnormal_bone_remodeling | 0.64073404 |
| 107 | MP0001986_abnormal_taste_sensitivity | 0.63914563 |
| 108 | MP0002928_abnormal_bile_duct | 0.63602741 |
| 109 | MP0003806_abnormal_nucleotide_metabolis | 0.62503213 |
| 110 | MP0010630_abnormal_cardiac_muscle | 0.61359394 |
| 111 | MP0008874_decreased_physiological_sensi | 0.61000895 |
| 112 | MP0009763_increased_sensitivity_to | 0.60459192 |
| 113 | MP0004858_abnormal_nervous_system | 0.60369870 |
| 114 | MP0000477_abnormal_intestine_morphology | 0.59980488 |
| 115 | MP0000733_abnormal_muscle_development | 0.59215850 |
| 116 | MP0001730_embryonic_growth_arrest | 0.58678732 |
| 117 | MP0000569_abnormal_digit_pigmentation | 0.58572901 |
| 118 | MP0009765_abnormal_xenobiotic_induced | 0.57893701 |
| 119 | MP0005166_decreased_susceptibility_to | 0.56902859 |
| 120 | MP0005075_abnormal_melanosome_morpholog | 0.56445255 |
| 121 | MP0003453_abnormal_keratinocyte_physiol | 0.56064864 |
| 122 | MP0004185_abnormal_adipocyte_glucose | 0.56037100 |
| 123 | MP0005381_digestive/alimentary_phenotyp | 0.54614738 |
| 124 | MP0001849_ear_inflammation | 0.49001281 |
| 125 | MP0005319_abnormal_enzyme/_coenzyme | 0.45774807 |
| 126 | MP0002693_abnormal_pancreas_physiology | 0.45592668 |
| 127 | MP0001348_abnormal_lacrimal_gland | 0.45244714 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 5.27843174 |
| 2 | Cellulitis (HP:0100658) | 4.67526782 |
| 3 | IgM deficiency (HP:0002850) | 4.65890809 |
| 4 | Colitis (HP:0002583) | 4.37685331 |
| 5 | Recurrent bronchitis (HP:0002837) | 4.37607109 |
| 6 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.35506985 |
| 7 | Orchitis (HP:0100796) | 4.34985743 |
| 8 | Recurrent viral infections (HP:0004429) | 4.31251116 |
| 9 | Inflammation of the large intestine (HP:0002037) | 4.22029062 |
| 10 | Panhypogammaglobulinemia (HP:0003139) | 4.21141840 |
| 11 | Gastrointestinal inflammation (HP:0004386) | 4.18805286 |
| 12 | Recurrent abscess formation (HP:0002722) | 4.05089060 |
| 13 | Chronic otitis media (HP:0000389) | 3.99670433 |
| 14 | Retrobulbar optic neuritis (HP:0100654) | 3.93917747 |
| 15 | Optic neuritis (HP:0100653) | 3.93917747 |
| 16 | Stomatitis (HP:0010280) | 3.93537142 |
| 17 | Verrucae (HP:0200043) | 3.90313383 |
| 18 | Papilloma (HP:0012740) | 3.90313383 |
| 19 | Gastrointestinal stroma tumor (HP:0100723) | 3.87404897 |
| 20 | Recurrent fungal infections (HP:0002841) | 3.79898021 |
| 21 | Meningitis (HP:0001287) | 3.71418167 |
| 22 | Eczematoid dermatitis (HP:0000976) | 3.65738823 |
| 23 | Abnormality of the fingertips (HP:0001211) | 3.55537850 |
| 24 | Spontaneous hematomas (HP:0007420) | 3.52370035 |
| 25 | Gastrointestinal infarctions (HP:0005244) | 3.51714529 |
| 26 | Recurrent bacterial skin infections (HP:0005406) | 3.48580603 |
| 27 | Lymphopenia (HP:0001888) | 3.37094960 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 3.26980467 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.26980467 |
| 30 | Abnormality of the nasal mucosa (HP:0000433) | 3.25507326 |
| 31 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.25073151 |
| 32 | Recurrent sinusitis (HP:0011108) | 3.22041439 |
| 33 | Gingivitis (HP:0000230) | 3.19618400 |
| 34 | Nasal polyposis (HP:0100582) | 3.18114967 |
| 35 | T lymphocytopenia (HP:0005403) | 3.16772890 |
| 36 | Urticaria (HP:0001025) | 3.15081071 |
| 37 | Abnormality of T cells (HP:0002843) | 3.12834452 |
| 38 | Emphysema (HP:0002097) | 3.11309668 |
| 39 | Pustule (HP:0200039) | 3.01886531 |
| 40 | Hematochezia (HP:0002573) | 2.99622444 |
| 41 | Abnormality of T cell number (HP:0011839) | 2.99601786 |
| 42 | Abnormality of T cell physiology (HP:0011840) | 2.94989631 |
| 43 | Prolonged bleeding time (HP:0003010) | 2.94498297 |
| 44 | Vasculitis (HP:0002633) | 2.92844560 |
| 45 | Autoimmune thrombocytopenia (HP:0001973) | 2.91500969 |
| 46 | Recurrent skin infections (HP:0001581) | 2.89712401 |
| 47 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.85689756 |
| 48 | Keratoconjunctivitis sicca (HP:0001097) | 2.81279819 |
| 49 | Thrombocytosis (HP:0001894) | 2.80975847 |
| 50 | Osteomyelitis (HP:0002754) | 2.78862338 |
| 51 | Cerebral aneurysm (HP:0004944) | 2.76740415 |
| 52 | Thyroiditis (HP:0100646) | 2.74943879 |
| 53 | Myositis (HP:0100614) | 2.73623307 |
| 54 | Hypochromic anemia (HP:0001931) | 2.69119133 |
| 55 | Chronic sinusitis (HP:0011109) | 2.69053161 |
| 56 | Hemoptysis (HP:0002105) | 2.66292270 |
| 57 | B lymphocytopenia (HP:0010976) | 2.65098700 |
| 58 | Abnormality of B cell number (HP:0010975) | 2.65098700 |
| 59 | Mediastinal lymphadenopathy (HP:0100721) | 2.64083063 |
| 60 | IgA deficiency (HP:0002720) | 2.59597024 |
| 61 | Hypochromic microcytic anemia (HP:0004840) | 2.56894109 |
| 62 | Keratoconjunctivitis (HP:0001096) | 2.55320839 |
| 63 | Increased IgM level (HP:0003496) | 2.55293881 |
| 64 | Chronic diarrhea (HP:0002028) | 2.47465293 |
| 65 | Chronic obstructive pulmonary disease (HP:0006510) | 2.45187803 |
| 66 | Obstructive lung disease (HP:0006536) | 2.45187803 |
| 67 | Interstitial pulmonary disease (HP:0006530) | 2.43650531 |
| 68 | Restrictive lung disease (HP:0002091) | 2.39211061 |
| 69 | Increased IgE level (HP:0003212) | 2.38741751 |
| 70 | Episodic fever (HP:0001954) | 2.37163416 |
| 71 | Increased density of long bones (HP:0006392) | 2.34291522 |
| 72 | Bronchitis (HP:0012387) | 2.33649926 |
| 73 | Purpura (HP:0000979) | 2.31072631 |
| 74 | Pulmonary embolism (HP:0002204) | 2.29768287 |
| 75 | Recurrent lower respiratory tract infections (HP:0002783) | 2.28705081 |
| 76 | Hypergammaglobulinemia (HP:0010702) | 2.28479482 |
| 77 | Sepsis (HP:0100806) | 2.26935123 |
| 78 | Impaired platelet aggregation (HP:0003540) | 2.26417683 |
| 79 | Abnormal platelet function (HP:0011869) | 2.26417683 |
| 80 | Epistaxis (HP:0000421) | 2.25785560 |
| 81 | Increased cerebral lipofuscin (HP:0011813) | 2.25302728 |
| 82 | Chest pain (HP:0100749) | 2.25063173 |
| 83 | Lymphoma (HP:0002665) | 2.24075403 |
| 84 | Petechiae (HP:0000967) | 2.22228396 |
| 85 | IgG deficiency (HP:0004315) | 2.21411868 |
| 86 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.21399407 |
| 87 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.21399407 |
| 88 | Abnormality of glycolipid metabolism (HP:0010969) | 2.21399407 |
| 89 | Combined immunodeficiency (HP:0005387) | 2.19428469 |
| 90 | Aortic aneurysm (HP:0004942) | 2.19183501 |
| 91 | Fatigue (HP:0012378) | 2.18873453 |
| 92 | Anorexia (HP:0002039) | 2.17750632 |
| 93 | Eosinophilia (HP:0001880) | 2.16258514 |
| 94 | Microcytic anemia (HP:0001935) | 2.16236900 |
| 95 | Recurrent pneumonia (HP:0006532) | 2.14665328 |
| 96 | Amyloidosis (HP:0011034) | 2.14388177 |
| 97 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.14161074 |
| 98 | Skin ulcer (HP:0200042) | 2.12777977 |
| 99 | Loss of speech (HP:0002371) | 2.10494327 |
| 100 | Dysostosis multiplex (HP:0000943) | 2.10132935 |
| 101 | Hepatosplenomegaly (HP:0001433) | 2.08882387 |
| 102 | Abnormality of the pleura (HP:0002103) | 2.08529054 |
| 103 | Viral hepatitis (HP:0006562) | 2.07899836 |
| 104 | Increased serum ferritin (HP:0003281) | 2.07588377 |
| 105 | Severe combined immunodeficiency (HP:0004430) | 2.07288356 |
| 106 | Hypertensive crisis (HP:0100735) | 2.06748974 |
| 107 | Abnormality of the peritoneum (HP:0002585) | 2.03774776 |
| 108 | Leukocytosis (HP:0001974) | 2.03296539 |
| 109 | Premature loss of primary teeth (HP:0006323) | 2.02997907 |
| 110 | Basal cell carcinoma (HP:0002671) | 2.02819137 |
| 111 | Encephalitis (HP:0002383) | 2.01641731 |
| 112 | Arterial thrombosis (HP:0004420) | 2.00238222 |
| 113 | Granulocytopenia (HP:0001913) | 1.99853026 |
| 114 | Recurrent otitis media (HP:0000403) | 1.99261341 |
| 115 | Polycythemia (HP:0001901) | 1.98920783 |
| 116 | Leukopenia (HP:0001882) | 1.98507581 |
| 117 | Hyperacusis (HP:0010780) | 1.98326755 |
| 118 | Abnormal platelet volume (HP:0011876) | 1.97497607 |
| 119 | Bicuspid aortic valve (HP:0001647) | 1.95574432 |
| 120 | Skin rash (HP:0000988) | 1.94409817 |
| 121 | Autoimmune hemolytic anemia (HP:0001890) | 1.93508393 |
| 122 | Peritonitis (HP:0002586) | 1.91439324 |
| 123 | Arthralgia (HP:0002829) | 1.91055660 |
| 124 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.90860306 |
| 125 | Periodontitis (HP:0000704) | 1.89945593 |
| 126 | Glomerulopathy (HP:0100820) | 1.89257927 |
| 127 | Systemic lupus erythematosus (HP:0002725) | 1.88741439 |
| 128 | Abnormality of macrophages (HP:0004311) | 1.88407756 |
| 129 | Abnormality of iron homeostasis (HP:0011031) | 1.87375851 |
| 130 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.87195984 |
| 131 | Abnormality of eosinophils (HP:0001879) | 1.86719985 |
| 132 | Pulmonary infiltrates (HP:0002113) | 1.85290303 |
| 133 | Thoracic kyphosis (HP:0002942) | 1.84950750 |
| 134 | Spondylolisthesis (HP:0003302) | 1.84147944 |
| 135 | High pitched voice (HP:0001620) | 1.83168131 |
| 136 | Gingival bleeding (HP:0000225) | 1.82175790 |
| 137 | Disproportionate tall stature (HP:0001519) | 1.81332557 |
| 138 | Long eyelashes (HP:0000527) | 1.79321299 |
| 139 | Mitral stenosis (HP:0001718) | 1.79182114 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.55323320 |
| 2 | MAP3K10 | 3.57339464 |
| 3 | EEF2K | 3.26708195 |
| 4 | PRPF4B | 3.14955107 |
| 5 | ERN1 | 2.57682867 |
| 6 | STK10 | 2.55343094 |
| 7 | TGFBR2 | 2.52749771 |
| 8 | GRK6 | 2.35788237 |
| 9 | PKN2 | 2.23651075 |
| 10 | CSF1R | 2.23647148 |
| 11 | TYK2 | 2.22617320 |
| 12 | TRIB3 | 2.15074318 |
| 13 | BLK | 2.11794536 |
| 14 | JAK3 | 2.06798676 |
| 15 | BTK | 2.06794517 |
| 16 | ZAP70 | 2.04506840 |
| 17 | LRRK2 | 1.76785530 |
| 18 | SIK2 | 1.74519950 |
| 19 | KDR | 1.72667631 |
| 20 | SYK | 1.68763471 |
| 21 | KIT | 1.57972833 |
| 22 | MAP3K3 | 1.54859999 |
| 23 | CDK12 | 1.52086943 |
| 24 | JAK1 | 1.51967345 |
| 25 | MAP2K3 | 1.51224838 |
| 26 | ITK | 1.50762207 |
| 27 | TBK1 | 1.48746879 |
| 28 | SMG1 | 1.40303383 |
| 29 | CSK | 1.38027823 |
| 30 | HCK | 1.36490406 |
| 31 | CLK1 | 1.33658324 |
| 32 | TXK | 1.32109387 |
| 33 | IRAK4 | 1.31199219 |
| 34 | FES | 1.30705485 |
| 35 | IKBKE | 1.30416356 |
| 36 | NEK2 | 1.27218767 |
| 37 | LCK | 1.24566040 |
| 38 | MAP3K1 | 1.22744954 |
| 39 | TAOK2 | 1.20947206 |
| 40 | MAP3K13 | 1.20797404 |
| 41 | FGFR4 | 1.20749578 |
| 42 | RPS6KA4 | 1.17602016 |
| 43 | MAP3K14 | 1.17384839 |
| 44 | MARK3 | 1.15337830 |
| 45 | EPHB1 | 1.15259663 |
| 46 | FGR | 1.12595583 |
| 47 | TEC | 1.11898686 |
| 48 | RIPK4 | 1.09194444 |
| 49 | PIM1 | 1.03544120 |
| 50 | CDK4 | 1.03055072 |
| 51 | PTK6 | 1.02198122 |
| 52 | LYN | 1.01968274 |
| 53 | TTN | 1.01695054 |
| 54 | IRAK3 | 0.94963577 |
| 55 | IKBKB | 0.94119215 |
| 56 | FGFR3 | 0.91341397 |
| 57 | CDC42BPA | 0.90282797 |
| 58 | FLT3 | 0.88184444 |
| 59 | CAMK1D | 0.82828433 |
| 60 | STK4 | 0.81337984 |
| 61 | KSR2 | 0.78147489 |
| 62 | SIK1 | 0.74887894 |
| 63 | SCYL2 | 0.74186101 |
| 64 | PRKCH | 0.73585931 |
| 65 | MAP3K7 | 0.72902432 |
| 66 | TIE1 | 0.72605603 |
| 67 | PAK4 | 0.71833135 |
| 68 | TNK2 | 0.71340515 |
| 69 | NLK | 0.69859079 |
| 70 | PDPK1 | 0.69653388 |
| 71 | TGFBR1 | 0.67925357 |
| 72 | JAK2 | 0.67569493 |
| 73 | RPS6KB2 | 0.67052088 |
| 74 | MAPK12 | 0.66927289 |
| 75 | CHUK | 0.66257927 |
| 76 | CAMK1G | 0.65327277 |
| 77 | MAP3K8 | 0.63623017 |
| 78 | MAPK7 | 0.63388660 |
| 79 | BMPR2 | 0.62349568 |
| 80 | FYN | 0.58819121 |
| 81 | PRKD2 | 0.58791715 |
| 82 | YES1 | 0.58272692 |
| 83 | CDK6 | 0.56413501 |
| 84 | IRAK2 | 0.56336393 |
| 85 | NME2 | 0.56152550 |
| 86 | TRPM7 | 0.54717305 |
| 87 | CDK9 | 0.54056767 |
| 88 | BRD4 | 0.53916648 |
| 89 | MAPK11 | 0.52725375 |
| 90 | HIPK2 | 0.52486527 |
| 91 | IRAK1 | 0.52363060 |
| 92 | PRKCQ | 0.51423074 |
| 93 | DYRK1B | 0.51161668 |
| 94 | ALK | 0.50379825 |
| 95 | MAPKAPK3 | 0.49787268 |
| 96 | SIK3 | 0.48885216 |
| 97 | MAP3K6 | 0.46828827 |
| 98 | CAMKK1 | 0.45829132 |
| 99 | MAPK4 | 0.45197680 |
| 100 | TESK2 | 0.44160164 |
| 101 | CDC7 | 0.43309728 |
| 102 | MAPKAPK2 | 0.42168682 |
| 103 | PDK1 | 0.41897059 |
| 104 | MAP2K6 | 0.40984253 |
| 105 | PTK2B | 0.40349895 |
| 106 | DMPK | 0.39381342 |
| 107 | ICK | 0.39299392 |
| 108 | CDK19 | 0.39180940 |
| 109 | RIPK1 | 0.37923695 |
| 110 | RPS6KA6 | 0.37464642 |
| 111 | MAP2K2 | 0.37395475 |
| 112 | MELK | 0.36082671 |
| 113 | BMX | 0.35784851 |
| 114 | ABL1 | 0.35425706 |
| 115 | PRKG2 | 0.35116024 |
| 116 | MARK2 | 0.34454339 |
| 117 | STK11 | 0.34281848 |
| 118 | MAP3K11 | 0.34069919 |
| 119 | RPS6KA2 | 0.34062365 |
| 120 | PIK3CG | 0.33569293 |
| 121 | RET | 0.32243332 |
| 122 | MTOR | 0.31748681 |
| 123 | MATK | 0.31546236 |
| 124 | TAOK1 | 0.31482873 |
| 125 | MAP3K5 | 0.31253879 |
| 126 | TAOK3 | 0.30823115 |
| 127 | ATR | 0.30661440 |
| 128 | PRKD1 | 0.30361050 |
| 129 | RPS6KL1 | 0.30129612 |
| 130 | RPS6KC1 | 0.30129612 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.30328726 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.70779078 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.66953119 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.35006081 |
| 5 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.28034917 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.27808953 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.22535951 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.20635155 |
| 9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.14708876 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.05138251 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.00028649 |
| 12 | Measles_Homo sapiens_hsa05162 | 1.98050009 |
| 13 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.96842880 |
| 14 | Asthma_Homo sapiens_hsa05310 | 1.93391531 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.84856457 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.73688657 |
| 17 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.73282044 |
| 18 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.64872052 |
| 19 | DNA replication_Homo sapiens_hsa03030 | 1.61835882 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.56572065 |
| 21 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.55643266 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.50671391 |
| 23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.45793546 |
| 24 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.45191429 |
| 25 | Platelet activation_Homo sapiens_hsa04611 | 1.44238042 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.42990644 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.40339357 |
| 28 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.37690323 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.37266452 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.36898602 |
| 31 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.35653572 |
| 32 | Hepatitis B_Homo sapiens_hsa05161 | 1.34338637 |
| 33 | Shigellosis_Homo sapiens_hsa05131 | 1.33145679 |
| 34 | Base excision repair_Homo sapiens_hsa03410 | 1.31026090 |
| 35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.29354069 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.24930876 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.23905796 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.23538422 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.22880184 |
| 40 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.22748988 |
| 41 | Tuberculosis_Homo sapiens_hsa05152 | 1.19270279 |
| 42 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.18832583 |
| 43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.17972810 |
| 44 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.16607235 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.15812272 |
| 46 | Phagosome_Homo sapiens_hsa04145 | 1.15786458 |
| 47 | Mismatch repair_Homo sapiens_hsa03430 | 1.12939204 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.12541335 |
| 49 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.12027501 |
| 50 | HTLV-I infection_Homo sapiens_hsa05166 | 1.11810621 |
| 51 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.11280257 |
| 52 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.07947110 |
| 53 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.07420722 |
| 54 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.05982960 |
| 55 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.04867412 |
| 56 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.04325159 |
| 57 | Pertussis_Homo sapiens_hsa05133 | 1.03831352 |
| 58 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.02760664 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.02240008 |
| 60 | Malaria_Homo sapiens_hsa05144 | 1.01695092 |
| 61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.01408893 |
| 62 | Legionellosis_Homo sapiens_hsa05134 | 0.95986117 |
| 63 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.95394357 |
| 64 | Colorectal cancer_Homo sapiens_hsa05210 | 0.94229939 |
| 65 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.86632292 |
| 66 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.86538711 |
| 67 | Ribosome_Homo sapiens_hsa03010 | 0.84390851 |
| 68 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83905572 |
| 69 | Salmonella infection_Homo sapiens_hsa05132 | 0.78830555 |
| 70 | Spliceosome_Homo sapiens_hsa03040 | 0.77586516 |
| 71 | Cell cycle_Homo sapiens_hsa04110 | 0.72948240 |
| 72 | Lysine degradation_Homo sapiens_hsa00310 | 0.72797954 |
| 73 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.72678133 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 0.70265022 |
| 75 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.68356314 |
| 76 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.67977917 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.67522639 |
| 78 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66271439 |
| 79 | Endocytosis_Homo sapiens_hsa04144 | 0.65363179 |
| 80 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63620176 |
| 81 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.61148287 |
| 82 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60970113 |
| 83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60701195 |
| 84 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59583410 |
| 85 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58789699 |
| 86 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.58502387 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57969828 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56847007 |
| 89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55913909 |
| 90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55352517 |
| 91 | Lysosome_Homo sapiens_hsa04142 | 0.53419890 |
| 92 | Focal adhesion_Homo sapiens_hsa04510 | 0.52613906 |
| 93 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52362550 |
| 94 | Homologous recombination_Homo sapiens_hsa03440 | 0.52153193 |
| 95 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.51762990 |
| 96 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.50879708 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49239970 |
| 98 | Pathways in cancer_Homo sapiens_hsa05200 | 0.49210582 |
| 99 | Amoebiasis_Homo sapiens_hsa05146 | 0.48873923 |
| 100 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48180330 |
| 101 | Prostate cancer_Homo sapiens_hsa05215 | 0.47803813 |
| 102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46581185 |
| 103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45265909 |
| 104 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.45242261 |
| 105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44945493 |
| 106 | Endometrial cancer_Homo sapiens_hsa05213 | 0.43064411 |
| 107 | Allograft rejection_Homo sapiens_hsa05330 | 0.43064405 |
| 108 | Glioma_Homo sapiens_hsa05214 | 0.42450984 |
| 109 | Adherens junction_Homo sapiens_hsa04520 | 0.40887627 |
| 110 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.40380282 |
| 111 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39831714 |
| 112 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.39498806 |
| 113 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37958268 |
| 114 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.36593048 |
| 115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35337140 |
| 116 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.33483680 |
| 117 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.33121190 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32501929 |
| 119 | Bladder cancer_Homo sapiens_hsa05219 | 0.31691644 |
| 120 | RNA transport_Homo sapiens_hsa03013 | 0.31211957 |
| 121 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.30086384 |
| 122 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.29870483 |
| 123 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.27791138 |
| 124 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.27492389 |

